—have emergency use authorization from the FDA. With new variants of the virus continuing to emerge, developing next-generation treatments is a top priority., researchers led by Dr. Jeffrey Glenn at Stanford University report that a single injection of that drug within three days of of the first symptoms reduced hospitalizations for COVID-19 by 51%, and deaths by 50%, among vaccinated people.
The current study involved nearly 2,000 people in Brazil and Canada and took place from June 2021 to February 2022, when several different variants were circulating, including Delta and the first versions of Omicron. About half of the participants were given the drug, and half a placebo. Because the treatment requires only a single shot administered by a doctor, compliance was 100%, and researchers observed minimal side effects.
The researchers believe that interferon lambda could also slow or even keep the virus from mutating to become resistant to other antiviral treatments, such as Paxlovid and molnupiravir. A recent
shove it up your ass
結核菌最強
Mientras HLGatell está tragando camote 🍠